Targeted AML therapy: new biologic paradigms and therapeutic opportunities

被引：11
|
作者：
Willman, CL
机构：
[1] Univ New Mexico, Hlth Sci Ctr, Canc Res Facil, Albuquerque, NM USA
[2] Univ New Mexico, Ctr Canc, Albuquerque, NM USA
来源：
LEUKEMIA | 2001年 / 15卷 / 04期
关键词：
D O I：
10.1038/sj.leu.2402087
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：690 / 694
页数：5
相关论文
共 50 条
  • [1] Targeted AML therapy: new biologic paradigms and therapeutic opportunities
    CL Willman
    Leukemia, 2001, 15 : 690 - 694
  • [2] IMMUNOTHERAPY FOR UROTHELIAL CANCER: NEW BIOLOGIC UNDERSTANDING AND NEW THERAPEUTIC OPPORTUNITIES
    Bajorin, Dean
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2016, 12 : 30 - 30
  • [3] Novel GPCR signaling paradigms : Opportunities for new therapeutic targets?
    Caron, M. G.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2010, 13 : 21 - 21
  • [4] Novel GPCR signaling paradigms: Opportunities for new therapeutic targets
    Caron, Marc G.
    ENDOCRINE JOURNAL, 2010, 57 : S303 - S303
  • [5] Biologic therapy for psoriasis - The new therapeutic frontier
    Singri, P
    West, DP
    Gordon, KB
    ARCHIVES OF DERMATOLOGY, 2002, 138 (05) : 657 - 663
  • [6] IGF system targeted therapy: Therapeutic opportunities for ovarian cancer
    Liefers-Visser, J. A. L.
    Meijering, R. A. M.
    Reyners, A. K. L.
    van der Zee, A. G. J.
    de Jong, S.
    CANCER TREATMENT REVIEWS, 2017, 60 : 90 - 99
  • [7] Targeted biologic therapy for asthma
    Hynes, Gareth
    Pavord, Ian D.
    BRITISH MEDICAL BULLETIN, 2020, 133 (01) : 16 - 35
  • [8] Antagonizing ClpP: A New Power Play in Targeted Therapy for AML
    Larkin, Karilyn
    Byrd, John C.
    CANCER CELL, 2015, 27 (06) : 747 - 749
  • [9] Targeted Therapy for Hepatocellular Carcinoma: Old and New Opportunities
    Laface, Carmelo
    Fedele, Palma
    Maselli, Felicia Maria
    Ambrogio, Francesca
    Foti, Caterina
    Molinari, Pasquale
    Ammendola, Michele
    Lioce, Marco
    Ranieri, Girolamo
    CANCERS, 2022, 14 (16)
  • [10] New therapeutic options for older unfit AML patients (excluding targeted therapies)
    Cerrano, Marco
    Itzykson, Raphael
    HEMATOLOGIE, 2021, 27 : 24 - 35
12345